Balanced business model
MorphoSys is focused on creating significant value for all of its stakeholders through a strategy that balances short- and long-term growth potential. By applying its proprietary technologies, MorphoSys has become a leader in the field of therapeutic antibodies. The company has established successful and lasting partnerships with industry-foremost companies from the pharmaceutical and biotechnology sectors. Our product pipeline, one of the broadest in the antibody industry, proves the sustainable quality of MorphoSys’ work. Through specific in-licensing and co-development activities, the company is adding higher-value programs to the pipeline at a significant rate. Our comprehensive partnering strategy is an important feature of our business model and a vital source of MorphoSys' financial strength.